Pharmacotherapy of xerostomia in primary Sjögren's syndrome.
We reviewed the current literature concerning the treatment of dry mouth in patients with primary Sjögren's syndrome (SJS). Computerized MEDLINE search engines were used with the terms Sjögren, xerostomia, dry mouth, and treatment. References from key articles were searched, and all pertinent articles were procured and reviewed. Primary SJS is an uncommon but serious disorder. Dry mouth caused by SJS can lead to dental erosion, dysphagia, oral infections, and discomfort. Preventing these complications is of paramount importance. Pharmacotherapy is limited to topical saliva substitutes, which are considered first, followed by muscarinic stimulators such as pilocarpine or cevimeline, if required. Immunosuppressive therapy is being investigated. Patients should have regular oral and dental examinations to detect complications. Satisfaction with the efficacy and tolerability of treatment should be monitored frequently. The clinician may have to use a trial-and-error approach to determine a successful regimen.
Wall
Geoffrey C
GC
Department of Pharmacy Practice, College of Pharmacy and Health Sciences, Drake University, Des Moines, Iowa 50311-4505, USA. geoff.wall@drake.edu
Magarity
Michelle L
ML
Jundt
Jeffrey W
JW
D006801:Humans; D012859:Sjogren's Syndrome / Q000150:complications* / Q000175:diagnosis / Q000473:pathology; D014987:Xerostomia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology